- Home
- ECPG vs BBNX Comparison
ECPG vs BBNX Comparison
Compare ECPG & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECPG
- BBNX
- Stock Information
- Founded
- ECPG 1998
- BBNX 2015
- Country
- ECPG United States
- BBNX United States
- Employees
- ECPG N/A
- BBNX N/A
- Industry
- ECPG Finance Companies
- BBNX Medical/Dental Instruments
- Sector
- ECPG Finance
- BBNX Health Care
- Exchange
- ECPG Nasdaq
- BBNX Nasdaq
- Market Cap
- ECPG 905.2M
- BBNX 740.7M
- IPO Year
- ECPG 1999
- BBNX 2025
- Fundamental
- Price
- ECPG $44.45
- BBNX $20.20
- Analyst Decision
- ECPG Strong Buy
- BBNX Strong Buy
- Analyst Count
- ECPG 3
- BBNX 10
- Target Price
- ECPG $62.67
- BBNX $24.40
- AVG Volume (30 Days)
- ECPG 306.3K
- BBNX 569.5K
- Earning Date
- ECPG 11-05-2025
- BBNX 07-29-2025
- Dividend Yield
- ECPG N/A
- BBNX N/A
- EPS Growth
- ECPG N/A
- BBNX N/A
- EPS
- ECPG N/A
- BBNX N/A
- Revenue
- ECPG $1,467,587,000.00
- BBNX $69,830,000.00
- Revenue This Year
- ECPG $25.19
- BBNX $42.80
- Revenue Next Year
- ECPG $7.22
- BBNX $34.58
- P/E Ratio
- ECPG N/A
- BBNX N/A
- Revenue Growth
- ECPG 15.50
- BBNX 38911.17
- 52 Week Low
- ECPG $26.45
- BBNX $8.89
- 52 Week High
- ECPG $51.77
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- ECPG 69.68
- BBNX N/A
- Support Level
- ECPG $41.24
- BBNX N/A
- Resistance Level
- ECPG $42.20
- BBNX N/A
- Average True Range (ATR)
- ECPG 1.11
- BBNX 0.00
- MACD
- ECPG 0.14
- BBNX 0.00
- Stochastic Oscillator
- ECPG 96.00
- BBNX 0.00
About ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.